Healthcare — Pharmaceutical
Pharma Marketing Agency
Ellington & Vale is a pharmaceutical marketing company working with pharma brands, formulations businesses and medical device companies in India — on brand, packaging, field collateral and professional communication, built inside the regulatory codes rather than around them.
What changed in 2024
The Uniform Code for Pharmaceutical Marketing Practices, 2024 and the parallel Uniform Code for Marketing Practices in Medical Devices, 2024 are the newest layer over Indian pharmaceutical marketing, and a great deal of material still in circulation predates them.
Among other provisions, the codes cap gifts to healthcare professionals at ₹1,000 per item and place tight limits on free sample distribution. Alongside them sit the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, which restricts efficacy claims for a schedule of conditions, and the Drugs and Cosmetics Act, 1940. Prescription medicines cannot be advertised to the public without prior Central Government approval.
The practical consequence for a marketing team: an audit of existing material is usually the honest first step, before anything new is produced on top of a foundation that may no longer comply.
Pharma brand and identity
Portfolio architecture is the recurring problem. A formulations business with sixty products, each named and packaged by whoever was available that quarter, has sixty unrelated brands and a company name that carries none of their equity.
The work is a naming and identity system that scales across a portfolio — so that a new product launch inherits recognition instead of starting from zero, and so that the company's own name means something to the doctors and distributors who see it most.
Packaging and cartons
Pharmaceutical packaging is where design meets regulation most directly. Cartons and labels carry mandatory declarations, and the layout has to accommodate them while remaining legible under real conditions — a pharmacist reading a strip quickly, a patient reading a carton in poor light.
Legibility here is a safety consideration, not an aesthetic preference. Look-alike and sound-alike packaging within a portfolio is a genuine dispensing-error risk, which makes differentiation across a product range a functional requirement rather than a branding nicety.
Our broader approach to structural and graphic packaging is on the packaging design page.
Field collateral and professional communication
Visual aids, detailing material, leave-behinds and the presentation a field force actually uses. This material has to do two things simultaneously: be persuasive to a busy clinician, and be defensible — every claim supported, every reference accurate, nothing that overstates what the data shows.
Material that overstates is not a marketing risk. It is a regulatory one, and it is the field force that is exposed when it is questioned.
Digital and patient education
Where permitted and appropriate: disease-awareness and patient-education material, professional-facing digital, and corporate communication. The line between education and promotion is the one that matters here, and it is drawn more tightly for prescription products than most teams assume.
What determines the cost
No published rates. What drives it: portfolio size and how many SKUs need packaging; whether an audit of existing material is in scope; whether field collateral is a one-off build or ongoing; and whether corporate brand work sits alongside product work. Tell us the scope and we'll give you a real read.
FAQ
- What does a pharma marketing agency do?
- Builds brand, packaging, field collateral and professional communication for pharmaceutical and medical device companies — within the regulatory codes governing what may be claimed and how healthcare professionals may be engaged.
- Can pharmaceutical products be advertised in India?
- Prescription medicines cannot be advertised to the public without prior Central Government approval, and the Drugs and Magic Remedies Act restricts efficacy claims for a schedule of specific conditions. Over-the-counter products face fewer restrictions but the same accuracy requirements. Most pharmaceutical marketing is therefore aimed at healthcare professionals and distributors rather than patients.
- Do you handle regulatory approval of marketing material?
- No. We build to the codes from the brief onward so that review is straightforward, but formal regulatory sign-off stays with your regulatory affairs team or counsel. We make their job smaller; we don't replace it.
- Do you design pharmaceutical packaging?
- Yes — cartons, labels and portfolio-wide packaging systems, with mandatory declarations designed in rather than added at the end. Differentiation across a range matters here for dispensing safety, not just for shelf presence.
- How much does pharma marketing cost in India?
- No published rates — see above for what drives it.
Your Next World
Let's create something distinctive.
Tell us what you are building. We will help give it the clarity, character and presence to be recognised.